Europe investigating rare nerve disorder after AstraZeneca shot – 7NEWS.com.au

Europes medicines regulator says it is reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZenecas COVID-19 vaccine and has requested more detailed data on the cases from the company.
As part of a regular review of safety reports for the vaccine, Vaxzevria, the European Medicines Agencys safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.
The EMA is also looking into reports of heart inflammation with Pfizer-BioNTechs…

Click here to view the original article.